Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Peixia Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: B7-H1 Antigen, Cell Cycle Proteins, Immunotherapy, Photochemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Taishan Scholar Project of Shandong Province, Shandong University.
Abstract (Originalsprache)
Photodynamic therapy is an efficient approach to promote cytotoxic T lymphocyte tumor infiltration to convert immunologically cold tumors into hot tumors through the induction of immunogenic cell death . However, tumors usually overexpress immune checkpoints such as PD-L1 to suppress T lymphocyte antitumor activity and evade immune surveillance. Therefore, the design of efficient photosensitizers to overcome checkpoint-mediated immune evasion is highly necessary. In this work, we report the design of BRD-PS, a BRD4-targeting photosensitizer, as a new class of immunomodulatory photosensitizer termed an immune checkpoint-modulating photosensitizer, to solve this issue. On one hand, BRD-PS induces immunogenic pyroptosis and ferroptosis to promote the activation and tumor infiltration of cytotoxic T cells. On the other hand, BRD-PS suppresses the expression of PD-L1 to avoid immune evasion. This work demonstrated the feasibility of utilizing a single photosensitizer to simultaneously induce immunogenic cell death and PD-L1 downregulation for synergistic cancer photoimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R.…
- Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, P. R. China.
- Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shenzhen Research Institute, Shandong University, Jinan, Shandong 250012, P. R. China.
ORCID-Profile: Xinke Zhang, Donghai Li, Gang Shan
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Taishan Scholar Project of Shandong Province
- Shandong University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, P., Du, Y., Qiu, J., Jiang, Q., Chen, W., Zhang, X., Li, G., Li, D., & Shan, G. (2024). Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01362
Vancouver
Li P, Du Y, Qiu J, Jiang Q, Chen W, Zhang X, et al. Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01362
BibTeX
@article{Li2024,
author = {Li, Peixia and Du, Yayin and Qiu, Jingru and Jiang, Qiaoyun and Chen, Weijia and Zhang, Xinke and Li, Guiling and Li, Donghai and Shan, Gang},
title = {Immune Checkpoint-Modulating Photosensitizer That Targets BRD4 for Cancer Photoimmunotherapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01362}
}
EUVIMED